カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ヒト用ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Human Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2479）◆商品コード：MMG23FB2479
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：128
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のヒト用ワクチン市場規模と予測を収録しています。・世界のヒト用ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のヒト用ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト用ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「水痘」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト用ワクチンのグローバル主要企業は、CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Indian Immunologicals、KANGH、Henan Grand Biopharma、ZhongKe Biopharm、Zhuoyi Biologicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト用ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト用ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン市場：タイプ別市場シェア、2022年
・水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン

世界のヒト用ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン市場：用途別市場シェア、2022年
・大人、子供

世界のヒト用ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト用ワクチンのグローバル売上、2018年-2023年
・主要企業におけるヒト用ワクチンのグローバル売上シェア、2022年
・主要企業におけるヒト用ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるヒト用ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Indian Immunologicals、KANGH、Henan Grand Biopharma、ZhongKe Biopharm、Zhuoyi Biological

*************************************************************

・調査・分析レポートの概要
ヒト用ワクチン市場の定義
市場セグメント
世界のヒト用ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト用ワクチン市場規模
世界のヒト用ワクチン市場規模：2022年 VS 2029年
世界のヒト用ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト用ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト用ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン
ヒト用ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
ヒト用ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別ヒト用ワクチン市場規模 2022年と2029年
地域別ヒト用ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Indian Immunologicals、KANGH、Henan Grand Biopharma、ZhongKe Biopharm、Zhuoyi Biological
...

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine. This report contains market size and forecasts of Human Vaccine in global, including the following market information:
Global Human Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Vaccine Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Human Vaccine companies in 2022 (%)
The global Human Vaccine market was valued at US$ 32870 million in 2022 and is projected to reach US$ 44570 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Human Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, by Type, 2022 (%)
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Global Human Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Human Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Vaccine revenues share in global market, 2022 (%)
Key companies Human Vaccine sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Human Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Vaccine, market overview.
Chapter 2: Global Human Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccine Overall Market Size
2.1 Global Human Vaccine Market Size: 2022 VS 2029
2.2 Global Human Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Human Vaccine Players in Global Market
3.2 Top Global Human Vaccine Companies Ranked by Revenue
3.3 Global Human Vaccine Revenue by Companies
3.4 Global Human Vaccine Sales by Companies
3.5 Global Human Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Vaccine Market Size Markets, 2022 & 2029
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, Tetanus
4.1.10 Pneumococcal
4.1.11 Rota vaccine
4.2 By Type – Global Human Vaccine Revenue & Forecasts
4.2.1 By Type – Global Human Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Human Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Human Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Human Vaccine Sales & Forecasts
4.3.1 By Type – Global Human Vaccine Sales, 2018-2023
4.3.2 By Type – Global Human Vaccine Sales, 2024-2029
4.3.3 By Type – Global Human Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Human Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Vaccine Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application – Global Human Vaccine Revenue & Forecasts
5.2.1 By Application – Global Human Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Human Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Human Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Human Vaccine Sales & Forecasts
5.3.1 By Application – Global Human Vaccine Sales, 2018-2023
5.3.2 By Application – Global Human Vaccine Sales, 2024-2029
5.3.3 By Application – Global Human Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Human Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Human Vaccine Revenue & Forecasts
6.2.1 By Region – Global Human Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Human Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Human Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Human Vaccine Sales & Forecasts
6.3.1 By Region – Global Human Vaccine Sales, 2018-2023
6.3.2 By Region – Global Human Vaccine Sales, 2024-2029
6.3.3 By Region – Global Human Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Human Vaccine Sales, 2018-2029
6.4.3 US Human Vaccine Market Size, 2018-2029
6.4.4 Canada Human Vaccine Market Size, 2018-2029
6.4.5 Mexico Human Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Human Vaccine Sales, 2018-2029
6.5.3 Germany Human Vaccine Market Size, 2018-2029
6.5.4 France Human Vaccine Market Size, 2018-2029
6.5.5 U.K. Human Vaccine Market Size, 2018-2029
6.5.6 Italy Human Vaccine Market Size, 2018-2029
6.5.7 Russia Human Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Human Vaccine Market Size, 2018-2029
6.5.9 Benelux Human Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Human Vaccine Sales, 2018-2029
6.6.3 China Human Vaccine Market Size, 2018-2029
6.6.4 Japan Human Vaccine Market Size, 2018-2029
6.6.5 South Korea Human Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Human Vaccine Market Size, 2018-2029
6.6.7 India Human Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Human Vaccine Sales, 2018-2029
6.7.3 Brazil Human Vaccine Market Size, 2018-2029
6.7.4 Argentina Human Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Vaccine Sales, 2018-2029
6.8.3 Turkey Human Vaccine Market Size, 2018-2029
6.8.4 Israel Human Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Human Vaccine Market Size, 2018-2029
6.8.6 UAE Human Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CNBG
7.1.1 CNBG Company Summary
7.1.2 CNBG Business Overview
7.1.3 CNBG Human Vaccine Major Product Offerings
7.1.4 CNBG Human Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CNBG Key News & Latest Developments
7.2 Changsheng Life
7.2.1 Changsheng Life Company Summary
7.2.2 Changsheng Life Business Overview
7.2.3 Changsheng Life Human Vaccine Major Product Offerings
7.2.4 Changsheng Life Human Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Changsheng Life Key News & Latest Developments
7.3 Zhifei
7.3.1 Zhifei Company Summary
7.3.2 Zhifei Business Overview
7.3.3 Zhifei Human Vaccine Major Product Offerings
7.3.4 Zhifei Human Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Zhifei Key News & Latest Developments
7.4 ChengDa Bio
7.4.1 ChengDa Bio Company Summary
7.4.2 ChengDa Bio Business Overview
7.4.3 ChengDa Bio Human Vaccine Major Product Offerings
7.4.4 ChengDa Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 ChengDa Bio Key News & Latest Developments
7.5 Kangtai
7.5.1 Kangtai Company Summary
7.5.2 Kangtai Business Overview
7.5.3 Kangtai Human Vaccine Major Product Offerings
7.5.4 Kangtai Human Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Kangtai Key News & Latest Developments
7.6 SINOVAC BIOTECH
7.6.1 SINOVAC BIOTECH Company Summary
7.6.2 SINOVAC BIOTECH Business Overview
7.6.3 SINOVAC BIOTECH Human Vaccine Major Product Offerings
7.6.4 SINOVAC BIOTECH Human Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 SINOVAC BIOTECH Key News & Latest Developments
7.7 Hissen
7.7.1 Hissen Company Summary
7.7.2 Hissen Business Overview
7.7.3 Hissen Human Vaccine Major Product Offerings
7.7.4 Hissen Human Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Hissen Key News & Latest Developments
7.8 Walvax Biotechnology
7.8.1 Walvax Biotechnology Company Summary
7.8.2 Walvax Biotechnology Business Overview
7.8.3 Walvax Biotechnology Human Vaccine Major Product Offerings
7.8.4 Walvax Biotechnology Human Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Walvax Biotechnology Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK Human Vaccine Major Product Offerings
7.9.4 GSK Human Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 GSK Key News & Latest Developments
7.10 SANOFI
7.10.1 SANOFI Company Summary
7.10.2 SANOFI Business Overview
7.10.3 SANOFI Human Vaccine Major Product Offerings
7.10.4 SANOFI Human Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 SANOFI Key News & Latest Developments
7.11 Rong An
7.11.1 Rong An Company Summary
7.11.2 Rong An Human Vaccine Business Overview
7.11.3 Rong An Human Vaccine Major Product Offerings
7.11.4 Rong An Human Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Rong An Key News & Latest Developments
7.12 NuoCheng Bio
7.12.1 NuoCheng Bio Company Summary
7.12.2 NuoCheng Bio Human Vaccine Business Overview
7.12.3 NuoCheng Bio Human Vaccine Major Product Offerings
7.12.4 NuoCheng Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 NuoCheng Bio Key News & Latest Developments
7.13 Hualan Bio
7.13.1 Hualan Bio Company Summary
7.13.2 Hualan Bio Human Vaccine Business Overview
7.13.3 Hualan Bio Human Vaccine Major Product Offerings
7.13.4 Hualan Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Hualan Bio Key News & Latest Developments
7.14 Tiantan biological
7.14.1 Tiantan biological Company Summary
7.14.2 Tiantan biological Business Overview
7.14.3 Tiantan biological Human Vaccine Major Product Offerings
7.14.4 Tiantan biological Human Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Tiantan biological Key News & Latest Developments
7.15 Changchun Baike
7.15.1 Changchun Baike Company Summary
7.15.2 Changchun Baike Business Overview
7.15.3 Changchun Baike Human Vaccine Major Product Offerings
7.15.4 Changchun Baike Human Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Changchun Baike Key News & Latest Developments
7.16 Adimmune
7.16.1 Adimmune Company Summary
7.16.2 Adimmune Business Overview
7.16.3 Adimmune Human Vaccine Major Product Offerings
7.16.4 Adimmune Human Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Adimmune Key News & Latest Developments
7.17 Zhongyianke Biotech
7.17.1 Zhongyianke Biotech Company Summary
7.17.2 Zhongyianke Biotech Business Overview
7.17.3 Zhongyianke Biotech Human Vaccine Major Product Offerings
7.17.4 Zhongyianke Biotech Human Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Zhongyianke Biotech Key News & Latest Developments
7.18 Bharat Biotech
7.18.1 Bharat Biotech Company Summary
7.18.2 Bharat Biotech Business Overview
7.18.3 Bharat Biotech Human Vaccine Major Product Offerings
7.18.4 Bharat Biotech Human Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Bharat Biotech Key News & Latest Developments
7.19 Bavarian Nordic
7.19.1 Bavarian Nordic Company Summary
7.19.2 Bavarian Nordic Business Overview
7.19.3 Bavarian Nordic Human Vaccine Major Product Offerings
7.19.4 Bavarian Nordic Human Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 Bavarian Nordic Key News & Latest Developments
7.20 Sanofi-Pasteur
7.20.1 Sanofi-Pasteur Company Summary
7.20.2 Sanofi-Pasteur Business Overview
7.20.3 Sanofi-Pasteur Human Vaccine Major Product Offerings
7.20.4 Sanofi-Pasteur Human Vaccine Sales and Revenue in Global (2018-2023)
7.20.5 Sanofi-Pasteur Key News & Latest Developments
7.21 Indian Immunologicals
7.21.1 Indian Immunologicals Company Summary
7.21.2 Indian Immunologicals Business Overview
7.21.3 Indian Immunologicals Human Vaccine Major Product Offerings
7.21.4 Indian Immunologicals Human Vaccine Sales and Revenue in Global (2018-2023)
7.21.5 Indian Immunologicals Key News & Latest Developments
7.22 KANGH
7.22.1 KANGH Company Summary
7.22.2 KANGH Business Overview
7.22.3 KANGH Human Vaccine Major Product Offerings
7.22.4 KANGH Human Vaccine Sales and Revenue in Global (2018-2023)
7.22.5 KANGH Key News & Latest Developments
7.23 Henan Grand Biopharma
7.23.1 Henan Grand Biopharma Company Summary
7.23.2 Henan Grand Biopharma Business Overview
7.23.3 Henan Grand Biopharma Human Vaccine Major Product Offerings
7.23.4 Henan Grand Biopharma Human Vaccine Sales and Revenue in Global (2018-2023)
7.23.5 Henan Grand Biopharma Key News & Latest Developments
7.24 ZhongKe Biopharm
7.24.1 ZhongKe Biopharm Company Summary
7.24.2 ZhongKe Biopharm Business Overview
7.24.3 ZhongKe Biopharm Human Vaccine Major Product Offerings
7.24.4 ZhongKe Biopharm Human Vaccine Sales and Revenue in Global (2018-2023)
7.24.5 ZhongKe Biopharm Key News & Latest Developments
7.25 Zhuoyi Biological
7.25.1 Zhuoyi Biological Company Summary
7.25.2 Zhuoyi Biological Business Overview
7.25.3 Zhuoyi Biological Human Vaccine Major Product Offerings
7.25.4 Zhuoyi Biological Human Vaccine Sales and Revenue in Global (2018-2023)
7.25.5 Zhuoyi Biological Key News & Latest Developments
8 Global Human Vaccine Production Capacity, Analysis
8.1 Global Human Vaccine Production Capacity, 2018-2029
8.2 Human Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccine Supply Chain Analysis
10.1 Human Vaccine Industry Value Chain
10.2 Human Vaccine Upstream Market
10.3 Human Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ヒト用ワクチンの世界市場見通し2023年-2029年(Human Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 組換えヒトチモシンベータ4タンパク質のグローバル市場展望 2023年-2029年：純度＞85%、純度＞95%、純度＞97%、その他
  • 複合ワクチンのグローバル市場展望 2023年-2029年：5価ワクチン、4価ワクチン、3価ワクチン、その他
  • ワクチンバイアルモニターの世界市場見通し2023年-2029年
  • ヒトiPSCの世界市場見通し2023年-2029年
  • 世界のヒトロタウイルスワクチン市場2022年：Rotarix、 RotaTeq、 Rotavac、 Rotavin-M1、 Lanzhou lamb、その他